Asymmetry Capital Management, L.P.
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Portfolio style
Measured from the filed 13F common-share book for Dec 31, 2021, never from the firm's own description.
Closest benchmark: the Dow Jones Industrial Average as of 2022-01-31, active share 89.2%; sector active share 67.7% against the combined 13F book's sector weights.
Over time 8 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
22 tracked positions · as of Dec 31, 2021 · Δ vs Sep 30, 2021Portfolio Trend
Sector Breakdown
As of Dec 31, 2021| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 76.5% | $136,409,813 |
| Unclassified | 23.5% | $41,838,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| KURA | Kura Oncology, Inc. | +307,966 | 502,275 | $7,031,850 | |
| — | +208,059 | 1,280,757 | $10,310,000 | ||
| — | +112,661 | 137,610 | $14,829,000 | ||
| — | +62,733 | 716,709 | $8,278,000 | ||
| — | +47,469 | 104,755 | $4,877,000 | ||
| — | +20,593 | 375,989 | $0 | ||
| — | +1,885 | 43,876 | $6,436,000 | ||
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| — | −89,964 | 185,201 | $4,687,000 | ||
| ACRS | Aclaris Therapeutics, Inc. | −43,208 | 198,493 | $2,886,088 | |
| CYTK | Cytokinetics Inc | −21,304 | 225,032 | $10,256,958 | |
| QTRX | Quanterix Corp | −18,729 | 143,204 | $6,071,849 | |
| PMVP | PMV Pharmaceuticals, Inc. | −3,202 | 97,680 | $2,256,408 | |
| — | −1,934 | 71,372 | $699,000 | ||
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 177,741 | $15,703,417 | |
| UNH | Unitedhealth Group Inc | 26,844 | $13,479,446 | |
| ABBV | AbbVie Inc. | 94,448 | $12,788,259 | |
| IQV | Iqvia Holdings Inc. | 44,314 | $12,502,751 | |
| CNC | Centene Corp | 148,254 | $12,216,129 | |
| JNJ | Johnson & Johnson | 55,755 | $9,538,007 | |
| NTRA | Natera, Inc. | 101,674 | $9,495,334 | |
| ARGX | Argenx SE | 20,881 | $7,312,317 | |
| — | 139,445 | $6,593,000 | ||
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALKS | Alkermes plc. | 373,382 | $11,515,100 | |
| MDT | Medtronic plc | 83,737 | $10,496,432 | |
| PODD | Insulet Corp | 36,732 | $10,440,336 | |
| — | 138,884 | $10,251,000 | ||
| — | 229,117 | $10,152,000 | ||
| — | 150,001 | $8,933,000 | ||
| PTCT | Ptc Therapeutics, Inc. | 215,985 | $8,036,801 | |
| KYMR | Kymera Therapeutics, Inc. | 89,071 | $5,232,030 | |
| BAX | Baxter International Inc | 61,570 | $4,952,075 | |
| AVTX | Avalo Therapeutics, Inc. | 534,621 | $1,165,473 | |
| GMTX | Disc Medicine, Inc. | 284,079 | $1,148,000 | |
| LRMR | Larimar Therapeutics, Inc. | 34,943 | $402,892 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
NEW | 177,741 | $15,703,417 | 8.81% | |
|
|
Added | 137,610 | $14,829,000 | 8.32% | ||
| UNH |
Unitedhealth Group Inc
Healthcare
|
NEW | 26,844 | $13,479,446 | 7.56% | |
| ABBV |
AbbVie Inc.
Healthcare
|
NEW | 94,448 | $12,788,259 | 7.17% | |
| IQV |
Iqvia Holdings Inc.
Healthcare
|
NEW | 44,314 | $12,502,751 | 7.01% | |
| CNC |
Centene Corp
Healthcare
|
NEW | 148,254 | $12,216,129 | 6.85% | |
|
|
Added | 1,280,757 | $10,310,000 | 5.78% | ||
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 225,032 | $10,256,958 | 5.75% | |
| JNJ |
Johnson & Johnson
Healthcare
|
NEW | 55,755 | $9,538,007 | 5.35% | |
| NTRA |
Natera, Inc.
Healthcare
|
NEW | 101,674 | $9,495,334 | 5.33% | |
|
|
Added | 716,709 | $8,278,000 | 4.64% | ||
| ARGX |
Argenx SE
Healthcare
|
NEW | 20,881 | $7,312,317 | 4.10% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Added | 502,275 | $7,031,850 | 3.94% | |
|
|
NEW | 139,445 | $6,593,000 | 3.70% | ||
|
|
Added | 43,876 | $6,436,000 | 3.61% | ||
| QTRX |
Quanterix Corp
Healthcare
|
Reduced | 143,204 | $6,071,849 | 3.41% | |
|
|
Added | 104,755 | $4,877,000 | 2.74% | ||
|
|
Reduced | 185,201 | $4,687,000 | 2.63% | ||
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
Reduced | 198,493 | $2,886,088 | 1.62% | |
| PMVP |
PMV Pharmaceuticals, Inc.
Healthcare
|
Reduced | 97,680 | $2,256,408 | 1.27% | |
|
|
Reduced | 71,372 | $699,000 | 0.39% | ||
|
|
Added | 375,989 | $0 | 0.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.